Common Cold News and Research RSS Feed - Common Cold News and Research

Sleep loss increases chance of catching a cold

Sleep loss increases chance of catching a cold

A new study led by a UC San Francisco sleep researcher supports what parents have been saying for centuries: to avoid getting sick, be sure to get enough sleep. [More]
Children increase parents’ risk for viral infection

Children increase parents’ risk for viral infection

The BIG LoVE (Utah Better Identification of Germs-Longitudinal Viral Epidemiology) study, led by scientists at the University of Utah School of Medicine, finds that each bundle of joy puts the entire household at increased risk for infection with viruses that cause colds, flu, and other respiratory illnesses. [More]
FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. [More]
Researchers develop diagnostic test to detect enterovirus D68

Researchers develop diagnostic test to detect enterovirus D68

Researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year. The outbreak caused infections at an unprecedented rate, with over 1,000 confirmed cases and 14 reported deaths nationwide, according to the Centers for Disease Control and Prevention. [More]
Canadian researchers launch world's first viral therapy clinical trial to attack and kill cancer cells

Canadian researchers launch world's first viral therapy clinical trial to attack and kill cancer cells

Canadian researchers have launched the world's first clinical trial of a novel investigational therapy that uses a combination of two viruses to attack and kill cancer cells, and stimulate an anti-cancer immune response. Previous research by this team and others worldwide suggests that this approach could be very powerful, and could have fewer side effects than conventional chemotherapy and radiation, although it will take years to rigorously test through this trial and others. [More]
Bidding for Health charity auction to raise funds in support of Immunodeficiency Canada

Bidding for Health charity auction to raise funds in support of Immunodeficiency Canada

Bidding for Health charity auction will raise much needed funds in support of a Canadian national registered charity Immunodeficiency Canada. 100% of proceeds raised will be used towards its programs and services. There is a wide range of exciting items to bid on with new items added throughout the month, so check back often. Something for all ages. [More]
Atopix raises additional development capital to investigate OC459 for treatment of asthma

Atopix raises additional development capital to investigate OC459 for treatment of asthma

Atopix Therapeutics Limited, a UK biopharmaceutical company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announced that it has raised additional development capital to advance its lead product OC459 for the treatment of asthma. [More]
Intermountain Healthcare participates in antibiotic stewardship forum at the White House

Intermountain Healthcare participates in antibiotic stewardship forum at the White House

Intermountain Healthcare is one of 150 organizations in the nation that was invited to the White House to help develop national policy to address the growing problem of the overuse of antibiotics. [More]
Talimogene laherparepvec treatment shows durable clinical responses in advanced-stage melanoma patients

Talimogene laherparepvec treatment shows durable clinical responses in advanced-stage melanoma patients

Research led by Howard L. Kaufman, MD, FACS, associate director for clinical science and chief surgical officer at Rutgers Cancer Institute of New Jersey and colleagues, shows advanced-stage melanoma patients have significant improvement in durable response rate and a trend toward improved survival when treated with a genetically-modified form of a herpes virus, whose native form causes the common cold sore. [More]
International study reveals that cold weather kills far more people than hot weather

International study reveals that cold weather kills far more people than hot weather

The study analysed over 74 million (74225200) deaths between 1985 and 2012 in 13 countries with a wide range of climates, from cold to subtropical... [More]
DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in oncolytic virus therapy, have entered into an exclusive clinical collaboration. Under the agreement, DNAtrix will utilize Alcyone's MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix's lead product for the treatment of the most aggressive form of brain cancer, glioblastoma (GBM). [More]
CMO Council announces the launch of global innovation ecosystem to advance UNICEF’s work

CMO Council announces the launch of global innovation ecosystem to advance UNICEF’s work

The Chief Marketing Officer (CMO) Council today announced the launch of a global CauseTech.net community and portal site, which is part of a new private sector initiative to crowdsource breakthrough ideas, inventions, products, and emerging technologies that can advance the work done by the UNICEF Global Innovation Center worldwide. [More]
Bronchitis can cause pneumonia, says Loyola physician

Bronchitis can cause pneumonia, says Loyola physician

When a cold has lasted too long or a cough is especially bothersome, it's important to see a medical professional. [More]
Scientists discover new way to control inflammation during worm infections and allergies

Scientists discover new way to control inflammation during worm infections and allergies

Research from The University of Manchester is bringing scientists a step closer to developing new therapies for controlling the body's response to allergies and parasitic worm infections. [More]
Montefiore physician offers tips for seasonal allergy sufferers

Montefiore physician offers tips for seasonal allergy sufferers

This winter was one of the coldest on record, but spring allergy season is already beginning and it's time for sufferers to start preparing now. [More]
Meta-analysis finds that high dose zinc acetate lozenges may help reduce duration of cold symptoms

Meta-analysis finds that high dose zinc acetate lozenges may help reduce duration of cold symptoms

According to a meta-analysis published in BMC Family Practice, high dose zinc acetate lozenges shortened the duration of common-cold associated nasal discharge by 34%, nasal congestion by 37%, scratchy throat by 33%, and cough by 46%. [More]
Finding could lead to more effective, less invasive treatment for 'bubble boy' disease

Finding could lead to more effective, less invasive treatment for 'bubble boy' disease

For infants with severe combined immunodeficiency (SCID), something as simple as a common cold or ear infection can be fatal. Born with an incomplete immune system, kids who have SCID--also known as "bubble boy" or "bubble baby" disease--can't fight off even the mildest of germs. [More]
Adults only really catch flu about twice a decade, suggests study

Adults only really catch flu about twice a decade, suggests study

Adults over the age of 30 only catch flu about twice a decade, a new study suggests. Flu-like illness can be caused by many pathogens, making it difficult to assess how often people are infected by influenza. [More]

Kinsa Groups launched to monitor overall health of children in U.S. public schools

Kinsa, the maker of the first FDA approved app-enabled smartphone thermometer, today announced the launch of Kinsa Groups for its iOS and Android apps. The Groups feature is currently available for public schools across the United States. With Kinsa Groups, parents can monitor the overall health at their child's school to better track, treat, and stop the spread of illness at the earliest signs of symptoms. [More]
Study reveals causes of community-acquired pneumonia in children

Study reveals causes of community-acquired pneumonia in children

With the chill of winter comes a spike in community-acquired pneumonia (CAP), which spreads more easily as people retreat indoors and come into close contact. The lung infection triggers persistent coughing, chest pain, fever, and difficulty breathing, and is particularly hard on the very young and the very old. In fact, pneumonia is the leading cause of hospitalization among U.S. children, with estimated medical costs of $1 billion annually. [More]
Advertisement
Advertisement